EricJamesDuncavageMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology & Immunology, Washington University School of Medicine

Dr. Duncavage is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110
Phone+1 314-362-5641

Fax+1 314-362-0369

University of Utah HealthFellowship, Hematopathology, 2009 - 2010
Washington University/B-JH/SLCH ConsortiumFellowship, Molecular Genetic Pathology, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2004 - 2008
University of Tennessee Health Science Center College of MedicineClass of 2004

PubMed

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the P...
Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder
Journal for Immunotherapy of Cancer. 2024-11-03
Head and neck squamous cell carcinomas of unknown primary: Can ancillary studies help identify more primary tumor sites?
Troy Hutchens, Wade Thorstad, Xiaowei Wang, Yuanxiang Li, Eric J Duncavage
Experimental and Molecular Pathology. 2024-08-01
1 citations
Analytical Validation of the Multitarget Stool RNA Test for Colorectal Cancer Screening.
Erica K Barnell, Jack Land, Kimberly Kruse, Maya C Scott, Ben Wedeking
The Journal of Molecular Diagnostics. 2024-08-01

Journal Articles

TP53 Immunohistochemistry Correlates TP53 Mutation Status and Clearance in Decitabine-Treated Patients with Myeloid Malignancies
John S Welch, Eric J Duncavage, Haematologica
Exome Analysis of Treatment‐Related AML After APL Suggests Secondary Evolution
John S Welch, Eric J Duncavage, Meagan A Jacoby, Peter Westervelt, Lukas D Wartman, British Journal of Haematology
Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGS
Jonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature

Abstracts/Posters

TGF-_ Signaling Contributes to Myelofibrosis and Clonal Dominance of Myeloproliferative Neoplasms
Eric J. Duncavage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Birthplace of Precision MedicineNovember 14th, 2024
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to ImmunotherapyNovember 7th, 2024
As Use of Large Cancer Panels and Whole-Genome Sequencing Expands, Illumina Plans to Future-Proof NGS Interpretation and ReportingMarch 28th, 2023
Join now to see all